Free Access
| Issue |
Med Sci (Paris)
Volume 33, Number 11, Novembre 2017
|
|
|---|---|---|
| Page(s) | 936 - 939 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20173311007 | |
| Published online | 04 December 2017 | |
- Bertucci F, Birnbaum D. Génomique et recherche clinique en cancérologie mammaire. Med Sci (Paris) 2012 ; 28 (hs1) : 14–18. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bertucci F, Finetti P, Birnbaum D. Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med 2012 ; 12 : 96–110. [CrossRef] [PubMed] [Google Scholar]
- Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001 ; 98 : 10869–10874. [CrossRef] [Google Scholar]
- Prat A, Adamo B, Cheang MC, et al. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 2013 ; 18 : 123–133. [CrossRef] [PubMed] [Google Scholar]
- Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011 ; 121 : 2750–2767. [CrossRef] [PubMed] [Google Scholar]
- Shah SP, Roth A, Goya R, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012 ; 486 : 395–399. [PubMed] [Google Scholar]
- Atchley DP, Albarracin CT, Lopez A, et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 2008 ; 26 : 4282–4288. [CrossRef] [PubMed] [Google Scholar]
- Loi S, Sirtaine N, Piette F, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02–98. J Clin Oncol 2013 ; 31 : 860–867. [CrossRef] [PubMed] [Google Scholar]
- Bianchini G, Balko JM, Mayer IA, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 2016 ; 13 : 674–690. [PubMed] [Google Scholar]
- M-Rabet M, Cabaud O, Josselin E, et al. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Ann Oncol 2017; 28 : 769–76. [PubMed] [Google Scholar]
- Takai Y, Miyoshi J, Ikeda W, Ogita H. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 2008 ; 9 : 603–615. [CrossRef] [PubMed] [Google Scholar]
- Fournier G, Garrido-Urbani S, Reymond N, Lopez M. Nectines et nectines-like. Med Sci (Paris) 2010 ; 26 : 273–279. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Brancati F, Fortugno P, Bottillo I, et al. Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome. Am J Hum Genet 2010 ; 87 : 265–273. [Google Scholar]
- Muhlebach MD, Mateo M, Sinn PL, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011 ; 480 : 530–533. [PubMed] [Google Scholar]
- Mateo M, Lopez M. Nectine-4, une protéine clé pour la transmission du virus de la rougeole. Med Sci (Paris) 2012 ; 28 : 363–365. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.